Afexa Life Sciences Inc.
TSX : CVQ

Afexa Life Sciences Inc.

April 03, 2007 08:00 ET

COLD-fX® is Canada's #1 Pharmacist Recommended Natural Cold Remedy for the Second Straight Year

EDMONTON, ALBERTA--(CCNMatthews - April 3, 2007) - Sixty-four percent of Canadian pharmacists polled recommend COLD-fX® as their first choice among natural cold remedies to their customers - up from 55% in 2005 - according to the 13th annual Pharmacy Post and L'actualite pharmaceutique survey on OTC Counselling and Recommendations of Pharmacists.

The survey also reveals that COLD-fX topped the recommendation list of Quebec pharmacists in the natural cold remedy category for the first time. CV Technologies Inc.(TSX:CVQ), maker of COLD-fX, said today that thirty-four percent of Quebec pharmacists surveyed recommend COLD-fX ahead of all other natural cold medicines - more than double its nearest competitor. The survey questionnaire was set out to 7,800 pharmacists between Oct.12 and Nov.6 last year.

The findings will be published in the April issue of Pharmacy Post and the May issue of L'actualite pharmaceutique. The mail-in survey was conducted by the research division of Roger's Healthcare and Financial Publishing for Pharmacy Post and L'actualite pharmaceutique - the key industry publications in Canada.

The results of the survey provide pharmacists with a comprehensive report on OTC counselling and recommendations which track pharmacists' thoughts and behaviours on non-prescription counselling and reveals which OTC brands pharmacists most often recommend to patients. "Pharmacy Post /L'actualite pharmaceutique's 13th annual OTC Market Report provides a snapshot of pharmacy's performance on more than 30 key nonprescription categories," says Janet Smith, Executive Publisher Drugstore and Grocery Retail Group at Roger's Publishing. "This is the industry's only comprehensive report on OTC Counselling and Recommendations. This report confirms pharmacists' importance in helping consumers choose the right non prescription product."

Across Canada, COLD-fX has been the # 1 pharmacist-recommended natural cold remedy for two years. It has also been ranked as the number one selling cold and flu remedy in Canada since October 2004. (ACNielsen's MarketTrack Drug Service for Cold Remedies, Natural Supplements & Vitamins Categories)

About Pharmacy Post Magazine

Pharmacy Post is Canada's drugstore news, OTC, business and front shop report for pharmacists, pharmacy owners and managers and buyers.

About L'actualite pharmaceutique

L'actualite pharmaceutique is a dynamic mix of news and drugstore channel information for the Quebec market.

About CV Technologies Inc.

CV Technologies, founded in 1992, is a global leader in the development and commercialization of naturally derived, evidence based, natural therapeutics for disease prevention and health maintenance. The Company's lead product - COLD-fX - strengthens the immune system and is widely used as a leading over the counter remedy (OTC) for preventing and relieving cold infections in Canada. In the United States it is marketed as an immune enhancing dietary supplement. COLD-fX, with its unique and patented mechanism of action was standardized according to the Company's ChemBioPrint (CBP) Process. The CBP process precisely identifies the chemical profile and biological activity of multi-active compounds in evidence-based natural therapeutics. The CBP process also provides a manufacturing protocol that ensures each batch of the final product delivers verifiable and provable health benefits. International manufacturing, marketing, patents and trademarks are held by fX Life Sciences International GmbH. COLD-fX is distributed and sold in the U.S. by COLD-fX Pharmaceuticals (USA) Inc. Both companies are wholly-owned subsidiaries of CV Technologies Inc. fX Life Sciences International GmbH and COLD-fX Pharmaceuticals (USA) Inc. maintain a call center for product information: 1-877-490-3300.

Contact Information